FNDC5 and early-onset autosomal dominant Alzheimer disease: Intravenous administration of AdFNDC5 led to increment of both plasma and hippocampal FNDC5/irisin expression, and restored novel object recognition (NOR) memory defects in Alzheimer’s disease (AD) mice (13).